Cadence Neuroscience

Cadence Neuroscience, Inc. is a clinical-stage medical device company founded in 2017 and headquartered in Redmond, Washington, developing a personalized neuromodulation system for pediatric and adult patients with focal drug-resistant epilepsy. Its implantable system, licensed from Mayo Clinic and incubated by a Mayo Clinic Rochester neurology and neurosurgery team, delivers chronic subthreshold cortical stimulation and detects EEG biomarkers of epileptiform activity in order to reduce or eliminate seizures. The company raised a $15M Series A in 2019 and a $26M Series B in 2023 led by the Angelini Lumira Biosciences Fund, with participation from F-Prime Capital, LivaNova USA, Angelini Ventures, Spectrum Financial Services and Mayo Clinic, and is using the proceeds to complete pivotal clinical studies and pursue FDA clearance. It is a regulated medical device manufacturer rather than a software vendor: it publishes no developer portal, public API, SDK or machine-readable API contract.

Cadence Neuroscience is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Health Care, Neurotechnology, and Neuromodulation.

🌐 Visit website 📡 Source on GitHub
5.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyMedical DevicesHealth CareNeurotechnologyNeuromodulationEpilepsyMedical TechnologyClinical Stage

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 5.1/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Commercial Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 3.9 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/cadence-neuroscience: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Cadence Neuroscience Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 3

The organization behind the API

Website
Website
 LinkedIn
LinkedIn
 Crunchbase
Crunchbase

Other 1

Properties that don't map to a standard resource type

SecondaryMarket
SecondaryMarket

Source (apis.yml)

apis.yml Raw ↑ 
aid: cadence-neuroscience
name: Cadence Neuroscience
description: 'Cadence Neuroscience, Inc. is a clinical-stage medical device company founded in 2017 and headquartered in Redmond,
  Washington, developing a personalized neuromodulation system for pediatric and adult patients with focal drug-resistant
  epilepsy. Its implantable system, licensed from Mayo Clinic and incubated by a Mayo Clinic Rochester neurology and neurosurgery
  team, delivers chronic subthreshold cortical stimulation and detects EEG biomarkers of epileptiform activity in order to
  reduce or eliminate seizures. The company raised a $15M Series A in 2019 and a $26M Series B in 2023 led by the Angelini
  Lumira Biosciences Fund, with participation from F-Prime Capital, LivaNova USA, Angelini Ventures, Spectrum Financial Services
  and Mayo Clinic, and is using the proceeds to complete pivotal clinical studies and pursue FDA clearance. It is a regulated
  medical device manufacturer rather than a software vendor: it publishes no developer portal, public API, SDK or machine-readable
  API contract.'
url: https://raw.githubusercontent.com/api-evangelist/cadence-neuroscience/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-08'
modified: '2026-08-08'
tags:
- Company
- Medical Devices
- Health Care
- Neurotechnology
- Neuromodulation
- Epilepsy
- Medical Technology
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/cadence-neuroscience-domain-security.yml
- type: Website
  url: https://cadenceneuro.com/
- type: LinkedIn
  url: https://www.linkedin.com/company/cadence-neuroscience-inc
- type: Crunchbase
  url: https://www.crunchbase.com/organization/cadence-neuroscience
- type: SecondaryMarket
  url: https://www.nasdaqprivatemarket.com/
x-enrichment:
  date: '2026-08-08'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: blocked
  reason: bot-challenge
  detail: Every path on cadenceneuro.com — homepage, /llms.txt and all /.well-known/* probes — answered HTTP 202 with a SiteGround
    anti-bot interstitial (a 169-byte meta-refresh to /.well-known/sgcaptcha/ carrying the sg-captcha challenge header) instead
    of the page, so not one page of the company's own surface could be read; DNS/TLS probes and third-party sources still
    completed.
  evidence:
  - url: https://cadenceneuro.com/
    status: 202
  - url: https://cadenceneuro.com/llms.txt
    status: 202
  - url: https://cadenceneuro.com/.well-known/security.txt
    status: 202
  - url: https://cadenceneuro.com/.well-known/agent-card.json
    status: 202
  checked: '2026-08-08'